Asian Race and Primary Open-Angle Glaucoma: Where Do We Stand?
- PMID: 35566612
- PMCID: PMC9099679
- DOI: 10.3390/jcm11092486
Asian Race and Primary Open-Angle Glaucoma: Where Do We Stand?
Abstract
Primary open-angle glaucoma (POAG) is an optic neuropathy characterized by irreversible retinal ganglion cell damage and visual field loss. The global POAG prevalence is estimated to be 3.05%, and near term is expected to significantly rise, especially within aging Asian populations. Primary angle-closure glaucoma disproportionately affects Asians, with up to four times greater prevalence of normal-tension glaucoma reported compared with high-tension glaucoma. Estimates for overall POAG prevalence in Asian populations vary, with Chinese and Indian populations representing the majority of future cases. Structural characteristics associated with glaucoma progression including the optic nerve head, retina, and cornea are distinct in Asians, serving as intermediates between African and European descent populations. Patterns in IOP suggest some similarities between races, with a significant inverse relationship between age and IOP only in Asian populations. Genetic differences have been suggested to play a role in these differences, however, a clear genetic pattern is yet to be established. POAG pathogenesis differs between Asians and other ethnicities, and it may differ within the broad classification of the Asian race. Greater awareness and further research are needed to improve treatment plans and outcomes for the increasingly high prevalence of normal tension glaucoma within aging Asian populations.
Keywords: Asian population; cornea; genetics; glaucoma; intraocular pressure; normal tension glaucoma; optic nerve head; primary open angle glaucoma; race; retina.
Conflict of interest statement
Alon Harris would like to disclose that he received remuneration from AdOM, Qlaris, Luseed, and Cipla for serving as a consultant, and he serves on the board of AdOM, Qlaris, and Phileas Pharma. Alon Harris holds an ownership interest in AdOM, Luseed, Oxymap, Qlaris, Phileas Pharma, SlitLed, and QuLent. All relationships listed above are pursuant to Icahn School of Medicine’s policy on outside activities. The contribution of the author Francesco Oddone was supported by Fondazione Roma and by the Italian Ministry of Health. None of the other authors listed have any financial disclosures. The authors declare no conflict of interest.
Similar articles
-
Quantitative differences between the optic nerve head and peripapillary retina in low-tension and high-tension primary open-angle glaucoma.Am J Ophthalmol. 1997 Dec;124(6):805-13. doi: 10.1016/s0002-9394(14)71698-8. Am J Ophthalmol. 1997. PMID: 9402827
-
Comparison of optic nerve head topography and visual field in eyes with open-angle and angle-closure glaucoma.Ophthalmology. 2008 Feb;115(2):239-245.e2. doi: 10.1016/j.ophtha.2007.03.086. Ophthalmology. 2008. PMID: 18082888
-
Open-angle glaucoma in an urban population in southern India: the Andhra Pradesh eye disease study.Ophthalmology. 2000 Sep;107(9):1702-9. doi: 10.1016/s0161-6420(00)00275-x. Ophthalmology. 2000. PMID: 10964833
-
Primary open-angle glaucoma.Nat Rev Dis Primers. 2016 Sep 22;2:16067. doi: 10.1038/nrdp.2016.67. Nat Rev Dis Primers. 2016. PMID: 27654570 Review.
-
[A challenge to primary open-angle glaucoma including normal-pressure. Clinical problems and their scientific solution].Nippon Ganka Gakkai Zasshi. 2012 Mar;116(3):233-67; discussion 268. Nippon Ganka Gakkai Zasshi. 2012. PMID: 22568103 Review. Japanese.
Cited by
-
Inhibition of TGF-β2-Induced Trabecular Meshwork Fibrosis by Pirfenidone.Transl Vis Sci Technol. 2023 Nov 1;12(11):21. doi: 10.1167/tvst.12.11.21. Transl Vis Sci Technol. 2023. PMID: 37975842 Free PMC article.
-
Metabolic syndrome as an independent risk factor for glaucoma: a nationally representative study.Diabetol Metab Syndr. 2023 Aug 24;15(1):177. doi: 10.1186/s13098-023-01151-5. Diabetol Metab Syndr. 2023. PMID: 37620923 Free PMC article.
-
Medical and surgical treatment management in open angle glaucoma patients of Asian descent: A narrative review.Eur J Ophthalmol. 2025 May 19:11206721251340435. doi: 10.1177/11206721251340435. Online ahead of print. Eur J Ophthalmol. 2025. PMID: 40388924 Free PMC article. Review.
-
Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment.Pharmaceuticals (Basel). 2023 Aug 22;16(9):1193. doi: 10.3390/ph16091193. Pharmaceuticals (Basel). 2023. PMID: 37765001 Free PMC article. Review.
-
Longitudinal changes in the intraocular pressure and their related factors among adults aged 40 to 64 years.Sci Rep. 2025 Mar 29;15(1):10918. doi: 10.1038/s41598-025-85835-0. Sci Rep. 2025. PMID: 40157951 Free PMC article.
References
-
- Kass M.A., Heuer D.K., Higginbotham E.J., Johnson C., Keltner J.L., Miller J.P., Parrish R.K., Wilson M.R., Gordon M.O. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 2002;120:701–713. doi: 10.1001/archopht.120.6.701. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources